chrisvoncsefalvay/vaers-outcomes huggingface dataset:
09/01/2021: 15 minutes post injection: Migraine, double vision, nausea S/S start. 09/01/2021: 2 hours post injection: Migraine, double vision, nausea S/S continue. Soreness in joint closest to injection sight, body chills, fatigue S/S begin. (Sleep from 21:30 09/01/2021 to 14:00 09/02/2021) 09/02/2021: Migraine, double vision, nausea, soreness, body chills, fatigue S/S continue. Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S begin. 09/03/2021: Migraine, double vision S/S subside. Nausea, soreness, body chills, fatigue, Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S continue. 09/04/2021: Nausea, soreness, body chills, fatigue, Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S continue. 09/05/2021: Nausea, soreness, body chills, fatigue, Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S continue. 09/06/2021: Nausea, soreness, body chills, fatigue S/S subside. Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S continue. 09/07/2021: Shortness of breath, chest pain running down right arm with rapid heart rate increase S/S continue. Check in at Emergency Department for exam. EKG, blood analysis, COVID test completed. All test showed no signs of COVID, no signs of heart damage, and regular heart activity. Dr stated that they believed continued S/S to be remnants of the side effects suffered from the first dose of the vaccine.
Developed a red, bumpy rash on my lower arms bilaterally and on my chest.  Some itching noted with the rash.  Upon looking back after the first COVID vaccination I did notice a couple of red areas on my arm but not enough to be concerned about.  The rash currently covers a large area on my arms, all below the elbows.  I was seen by my physician and prescribed a topical steroid cream.  The rash has not resolved.
itchiness; hard a circumference of a golf ball; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), INDURATION (hard a circumference of a golf ball) and ERYTHEMA (Redness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PRURITUS (itchiness), INDURATION (hard a circumference of a golf ball) and ERYTHEMA (Redness). At the time of the report, PRURITUS (itchiness), INDURATION (hard a circumference of a golf ball) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications include Benadryl cream for an unknown indication. No relevant concomitant medications were reported.
2 hours post vax pt started developing small rash (wheels) on the neck and back. Condition gradually increased and progressed to include extremities and face.  Pt was treated with diphenhydramine with no relief. Pt taken to the ER.
Leg pain in left leg began 08/17/2022 when kneeling, leg discomfort continued through 08/18/2022, sudden shortness of breath on 08/19/2022, diagnosed with blood clot in each lung and three DVTs in left leg, hospitalized overnight 08/19/2022-08/20/2022, Eliquis prescribed at time of discharge on 08/20/2022, shortness of breath and cough continue, as well as swelling in feet and lower legs.
Warmth, redness and swelling. Cool compress, Ibuprofen as needed.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 19-APR-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed temperature excursion two times. The total cumulative excursion time of the first time was 136 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 40 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Vertigo; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 23Mar2021 at 13:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation Medical history included possible Grave's Disease, untreated. Concomitant medications included amoxicillin and clavulanic acid (AUGMENTIN); levocabastine hydrochloride (ZYRTEC); MEGARED and Hibiscus Flower (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown start date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021 at 13:45, 30 minutes after vaccination, the patient experienced vertigo and vomiting. No therapeutic measures were taken for the adverse events. The clinical outcome of the events vertigo and vomiting was recovered on an unknown date at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Breakthrough case admission after 4th vaccine 2/27/21 Moderna Lot# 025A21A 3/23/21 Moderna Lott# 045A21A 10/22/21 Moderna Lot# 025D21A 4/11/22 Moderna Lot# 027L21A
Upon receiving vaccination felt tingling in left arm. Within 10 minutes experienced SOB, elevated HR, rash, whelps, elevated BP. Resolved with treatment with IVF, solumedrol, benedryl and Pepcid by ER provider.
fever of 38.5C; terrible ringing in the ears; heart rate was between 110 and 120; flu-like symptoms; This spontaneous case was reported by a health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), TINNITUS (terrible ringing in the ears), HEART RATE INCREASED (heart rate was between 110 and 120) and PYREXIA (fever of 38.5C) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included samotidine, SIMVASTATIN, PROGESTERONE, DIVIGEL cream, ANTITHYROID PREPARATIONS and VITAMINS NOS for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-1900, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). On 05-Feb-2021, the patient experienced TINNITUS (terrible ringing in the ears) and HEART RATE INCREASED (heart rate was between 110 and 120). On 06-Feb-2021, the patient experienced PYREXIA (fever of 38.5C). On 05-Feb-2021, HEART RATE INCREASED (heart rate was between 110 and 120) had resolved. On 07-Feb-2021, PYREXIA (fever of 38.5C) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) and TINNITUS (terrible ringing in the ears) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature: 38.5 (Inconclusive) 38.5.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included over the counter flavonoids.   This case was linked to MOD21-08524 (Patient Link).
Client did not state on the screening tool that she was asthmatic was immunized with Zoster and Pneuomococcal -23  and left the clinic for about five minutes. Returned to the clinic with her sister-in-law. Client was experiencing shortness of breath,skin clammy,right side lower back pain. Called 911 for assistance. 911 arrived within 7 minutes , in the mean time vital signs were assessed every five minutes, 150/88 initial, 84 pulse and 20 respirations. 911 assessed her and client left with family members. She refused to go to the hospital.
The syringe was not tight on the syringe and the vaccine leaked out while the needle was in her arm. The vaccine ran down her arm and onto the floor. I re-administered the vaccine.
11/4/02 total body itching. Rash all over body-not raised. Took Alpraxolamo any swelling or difficulty breathing. Resolved by 11am. Started 6:30pm. No call HCP.
Medication Error: Syringe and needle was not  well tighened. Patient was injected but vaccine  spilled out . Both vaccinator and patient were certain patient did not receive full dose (0.3 ) of vaccine. Clinical head was informed. A second shot was given in same arm per patient's preference. No adverse effects noted at this time. Patient was advised by clinical head. She was instructed to vsafe. A pfizer fact sheet was given. She was educated on what to expect after a covid-19 vaccine and observed for 30 min.
Approximately 4 days after receiving the first jab, my vision in my right eye suddenly deteriorated by the appearance of a field of 'floaters'.   The floaters were not blocking my vision, but instead made shadows on my vision field that were partially fixed in the vision field and partially floating, repositioning in my vision field due to gravity and inertial forces.  I did not report this to phone-bbased Vaers because the online form for doing so did not offer a selection related to vision changes, and so I thought at the time it must be medically preposterous that  and so you could say that the form needs to be revised.
sore arm; Ice or heat on injection; Ice or heat on injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (Ice or heat on injection) and VACCINATION SITE COLDNESS (Ice or heat on injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (Ice or heat on injection) and VACCINATION SITE COLDNESS (Ice or heat on injection). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (Ice or heat on injection) and VACCINATION SITE COLDNESS (Ice or heat on injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Heart Palpitations , Nausea , headache, arm hurting  No appetite Chest Pain  A lot of mild reactions  Pulse was over 100
9 cm X 5cm red whelp to (R) deltoid, not tender to touch, cellulitis. Treatment - BACTRIM DS
Fever of 102.1, headache, ringing in ears, body aches,  fatigue For 48 hours
2/11/2011: Vaccine dose 1. 2/19/2011: swollen lymph node behind ear-prescribed Keflex. 3/2/2011: maculopapular rash on entire body, possible reaction to Keflex (resolved within a week). 4/5/2011: Vaccine dose 2. 6/2011 to 7/2011: sudden fingertip heat, lasting a few seconds - intermittent. 7/2011 to 8/2011: toes of right foot felt less sensitive, almost asleep. 7/2011 to PRESENT: memory issues - difficulty remembering familiar proper names, words, simple spellings, basic details of recent events - intermittent. 9/2011 to 10/2011: periods of dizziness/brain fog lasting several hours, once or twice a day - intermittent. 9/20/2011: possible panic attack (pounding heart, heat in chest, out of the blue) - never experienced prior. Opted out of taking vaccine dose 3.
Approximately 30 hrs. after H1N1 MIV injection, experienced headache. By 32 hrs. post-injection experienced sore mid-back and rib cage pain, posterior lower leg pain, weakness and slight difficulty swallowing. Weakness and soreness, as well as dizziness persists 36 hrs. post injection.
This spontaneous report was received from a male nurse practitioner of unknown age via a field representative, referring to himself. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX vial (lot#, expiration date, concentration, route and frequency were unknown) in an unspecified arm for prophylaxis. On an unknown date, the patient developed "upper arm pain that went from his shoulder to his elbow for 3 weeks". The outcome of event was unknown. The causality between event and ZOSTAVAX was not provided. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1709USA001201:
Heart rate was in the 20?s. Watch woke me up with an alarm. Went to doctor ran an ekg  heart rate at office was 45. Referred to cardiologist and ended up at emergency room two times. By October 13 I was having an emergency pacemaker placed.
Red knot at the injection site; Warm to the touch knot at the injection site; Itchy knot; Tender knot; swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red knot at the injection site), INJECTION SITE WARMTH (Warm to the touch knot at the injection site), PRURITUS (Itchy knot), TENDERNESS (Tender knot) and INJECTION SITE SWELLING (swollen at the injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (Red knot at the injection site), INJECTION SITE WARMTH (Warm to the touch knot at the injection site), PRURITUS (Itchy knot), TENDERNESS (Tender knot) and INJECTION SITE SWELLING (swollen at the injection site). At the time of the report, INJECTION SITE ERYTHEMA (Red knot at the injection site), INJECTION SITE WARMTH (Warm to the touch knot at the injection site), PRURITUS (Itchy knot), TENDERNESS (Tender knot) and INJECTION SITE SWELLING (swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Based on MSA comment,  INJECTION SITE WARMTH,  PRURITUS, TENDERNESS and INJECTION SITE SWELLING (MAH causality assessment should be changed from "Not Provided" to "possibly Related"
was vacinated and still got this horrible ick/suspected vaccination failure; got this horrible ick; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient was vaccinated and still got shingles horrible ick. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown.
Delayed adverse reaction day 9 (1/7/21) arm was itchy. By nighttime red bullseye type mark on arm. No response to OTC hydrocortisone. On Friday, Saturday, and Sunday I took over the counter day time allergy meds without much relief.  Spot on arm continued growing nearly to elbow and was hot to touch. Sunday night switched to Benadryl. Itchy throughout entire body- tingly lips and nose, but no swelling to tongue.
Heart palpitations and atrial fibrillation, starting 5/3/2021 6:45 AM. Resolved by electric cardioversion on 5/3/2021 5:00 PM.
Difficulty walking. Blurry vision. 2 Emergency room visits 3 weeks after shot.  Diagnosed with FND cohen's hospital.
Got flu shot at Pharmacy yesterday at approximately 10:00a.m. Dizziness and vomiting at approximately 12 noon. Slight fever and joint aches. Lasted throughout day. Could not hold down ginger ale or water. I am 61 years old and a Type 1 diabetic. I could not report this on the vaccine site as it would not let me in due to privacy issues.
Possible viral infection, possible drug reaction, erythema multiforme. January, 2000 pt developed some posterior cervical adenopathy that was painless. One lymph node from back of neck was subsequently and showed reactive hyperplasia. 01/25 lymphadenopathy reported became widespread and painful. She experienced anorexia, and developed rash on trunk and arms, a fever of 102. 01/29 pt admitted to hospital due to dehydration, continued fevers, generalized severe painful  lymphadenopathy, mildly enlarged and tender liver and spleen, elevated liver enzymes, decreased albumin, and macular rash - confluent over 80% of body, face and feet. Skin biopsy revealed erythema multiforme. Also mild thrombocytopenia. Husband noted that she was improving. She completely recovery around 02/15. Discharge diagnosis was rash, fever, lymphadenopathy, and hepatosplenomegaly of unknown etiology, possibly viral infection although drug reaction is possible. During hospital stay, pt received fluids and medications for pain and itching.
admitted to the hospital with AHRF, bilateral pneumonia, acute renal failure; tested positive for COVID, FLU A, and strep; suffered cardiopulmonary arrest and died in the hospital 3 days after admission
This spontaneous report was received from a medical assistant refers to a 12-year-old non-pregnant female patient. The patient did not have any pertinent medical history, drug reactions or allergies. She was not taking any concomitant medications. On 18-OCT-2016, the patient was vaccinated with a dose of VAQTA (lot # M015290, expiration date 20-SEP-2017 (dose, route of administration and anatomical location were not reported)). On 18-OCT-2016, five minutes after receiving the VAQTA, the patient experienced fainting. On the same day (reported as one minute later), the patient recovered from fainting. The patient sought medical attention by contacting physician but there was no treatment given for the adverse event. No lab diagnostics studies were performed. The relatedness between fainting and VAQTA was not reported. This is one of two reports received from the same reporter. Additional information has been requested.
Loss of coordination, vomiting, diarrhea, chest tightness and difficulty breathing, chills, itchy skin, very fatigued
heavy cold; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (heavy cold) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient did not have COVID-19 in the past. Patient was not given any other vaccine within 1 month prior to Moderna COVID-19 vaccine.Patient did not have any history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination.  Concurrent medical conditions included Penicillin allergy, Drug allergy (lisinopril) and Drug allergy (amlodipine).   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2022, the patient experienced NASOPHARYNGITIS (heavy cold). On 28-Oct-2022, NASOPHARYNGITIS (heavy cold) had resolved.            No concomitant medications were reported.   No treatment medications were reported.   Reporter did not allow further contact
pt recvd vax on 9aug94;devel GBS commencing 20sep94 progressing to needing ventilator support a few days later;
1st dose of Shingrix in October 2019 / wants to get second dose.; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The registered nurse wanted to know how the patient should proceed with schedule if wants to get second dose of Shingrix. Till the time of reporting, the patient did not receive 2nd dose. The reporter did not consent to follow-up. The reporter provided limited information, no demographic details from patient were provided, Lot number neither expiration date were provided since information was not available.
MMR, VZV & TB skin test (PPD) given at 1230 pm - Mom noticed rash "all over legs" around 1 pm - returned to clinic. Advised to give BENADRYL as needed by MD.
On 9/13/2022, I had a tickle in my throat. On 9/14/2022, I had full blown sore throat, fever, was never higher than 101.5, some congestion, but no coughing. The coughing came later. The sore throat was one of the worse sore throats that I can remember having and it lasted a good 6 days or so. On 9/14/2022, I took a COVID-19 home test- negative. I flew on 9/15/2022. I was wearing a mask the whole time. That evening I took another COVID-19 test and it was positive. I stayed in the hotel and quarantined for 5 days.  I bought cough drops and cough medication for my symptoms. I sent the doctor an message, and they said to quarantine for 5 days and treat symptoms with cough drops and cough medication. Wednesday, 9/21/2022, I flew home. The symptoms kept lingering on and on 10/3/2022, I chatted with my doctor through the app and she prescribed Benzonatate capsule for cough and an inhaler with Albuterol on 10/3/2022. My cough is getting better, but I have had it for 5 weeks. I don't have a lot of energy, I don't have my full breath, and I have brain fog. I have a difficult time trying to remember words and names. I never lost my taste and smell.
PT. REC'D VACCINE AT 2:18PM, WAITED RECOMMENDED 15 MIN. AND CHECKED OUT AT 2:33PM.  T/C AT 2:42 PT CALLED AND C/O TINGLING TO LEFT SIDE OF FACE AND LIPS, AND C/O  A H/A THAT PT. REPORTS COULD POSSIBLY BE D/T STRESS/ANXIETY  OF THE TINGLING SENSATION. STAYED ON THE PHONE WITH HER WHILE SHE COMPLETED HER DRIVE TO THE WORK SITE. SPOKE WITH HUSBAND AND ASKED THAT HE GET BENADRYL AND ADMINISTER ASAP AND TO CALL IF SYMPTOMS WORSEN. T/C TO PT AT 3:12PM HAS TAKEN BENADRYL AND FEELS FINE.
3AM massive cramps, chest to thighs x 6 hrs-faintly; nauseated now, severe pain; no meds taken; 26FEB94 cont rest of doses; exp only mild nausea; no other sx or problems; inc fluids;